Stephen M. Condon
Nessuna posizione attualmente
Profilo
Stephen M.
Condon worked as a Principal at Shire ViroPharma, Inc. and Rhone Poulenc Rorer.
He also worked as Vice President-Chemistry at TetraLogic Pharmaceuticals Corp.
Condon holds a doctorate degree from the University of Pennsylvania, a graduate degree from the University of Georgia, and an undergraduate degree from the University of Massachusetts.
Precedenti posizioni note di Stephen M. Condon
Società | Posizione | Fine |
---|---|---|
Rhone Poulenc Rorer
Rhone Poulenc Rorer Chemicals: SpecialtyProcess Industries Part of Solvay SA, Rhone Poulenc Rorer is a French pharmaceutical company that manufactures and distributes pharmaceutical products. | Corporate Officer/Principal | 01/01/2000 |
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Corporate Officer/Principal | - |
TETRALOGIC PHARMACEUTICALS CORPORATION | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Stephen M. Condon
University of Pennsylvania | Doctorate Degree |
University of Massachusetts | Undergraduate Degree |
University of Georgia | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
TETRALOGIC PHARMACEUTICALS CORPORATION | Health Technology |
Aziende private | 2 |
---|---|
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Health Technology |
Rhone Poulenc Rorer
Rhone Poulenc Rorer Chemicals: SpecialtyProcess Industries Part of Solvay SA, Rhone Poulenc Rorer is a French pharmaceutical company that manufactures and distributes pharmaceutical products. | Process Industries |
- Borsa valori
- Insiders
- Stephen M. Condon